Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2003
05/22/2003US20030095997 Preferably collagen; capable of promoting formation of granulation tissue, angiogenesis, vascularization and epithelization; useful in surgical suturing.
05/22/2003US20030095995 Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
05/22/2003US20030095992 Altering a drug's distribution, metabolism and elimination properties, especially by modifying with aralkyl ester moieties to increase rate of metabolism to inactive and nontoxic metabolites when exposure is halted; surgery, riots
05/22/2003US20030095977 Use of fusion proteins, especially scFvSA, as diagnostic markers or as cell specific targeting agents.
05/22/2003US20030095976 Methods to improve immunogenicity of antigens and specificity of antibodies
05/22/2003US20030095963 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restriced differentiation antigen for treatment of B cell lymphoma
05/22/2003US20030095928 Nanoparticulate insulin
05/22/2003US20030095927 Provides biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect.
05/22/2003US20030094104 Process tolerant low amylose tapioca distarch adipates
05/22/2003CA2467433A1 Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
05/22/2003CA2467239A1 Catheter injectable depot compositions and uses thereof
05/22/2003CA2467167A1 High-concentration lidocaine compositions and methods for their preparation
05/22/2003CA2467052A1 Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
05/22/2003CA2466998A1 Biocompatible polymer blends and uses thereof
05/22/2003CA2466641A1 Lyophilized monoclonal antibody compositions
05/22/2003CA2466632A1 Injectable depot compositions and uses thereof
05/22/2003CA2466504A1 Oral dosage form of a sulfonamide prodrug
05/22/2003CA2466422A1 Methods and compositions for use of (s)-bisoprolol
05/22/2003CA2465334A1 Aspirin-containing transdermal pharmaceutical composition for the treatment of calcification
05/22/2003CA2463481A1 Three-dimensional suspension printing of dosage forms
05/22/2003CA2461481A1 Ptp1b inhibitors and ligands
05/21/2003EP1312380A1 Aseptics
05/21/2003EP1312377A2 Combined meningitis vaccine
05/21/2003EP1312366A1 Aqueous pharmaceutical compositions
05/21/2003EP1312360A1 Analgesic/antiinflammatory patches for topical use
05/21/2003EP1312356A1 Aqueous suspension preparations
05/21/2003EP1311679A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
05/21/2003EP1311674A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311668A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311662A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311522A1 New immunoeffector compounds
05/21/2003EP1311491A1 Use of triazinetrione sulfones for combating coccidiosis
05/21/2003EP1311474A1 Sulfonamide derivatives
05/21/2003EP1311296A2 Solution of an oxazolidinone antibiotic drug
05/21/2003EP1311285A2 Liquid pharmaceutical composition containing an erythropoietin derivative
05/21/2003EP1311280A2 Cell internalized peptide-drug conjugates
05/21/2003EP1311261A1 Medicaments for chemotherapeutic treatment of disease
05/21/2003EP1311259A2 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent
05/21/2003EP1311249A1 Transdermal therapeutic system
05/21/2003EP1311248A1 Transdermal therapeutic system for treating restless-legs-syndrome
05/21/2003EP1311244A2 Steroid hormones as transfer agents
05/21/2003EP1311243A2 Process for the production and use of powdered mannitol and mannitol-containing compositions
05/21/2003EP1311242A1 Active agent delivery systems and methods for protecting and administering active agents
05/21/2003EP1311241A2 Use of a porous carrier
05/21/2003EP1311239A1 Oral delivery of peptide
05/21/2003EP1311213A1 Vaginal delivery of bisphosphonates
05/21/2003EP1200066B1 Aqueous nasal formulation
05/21/2003EP1041895A4 Animal feed pelleting process and animal feed pellets produced therefrom
05/21/2003EP1017367B1 Methods for fabricating polymer-based controlled release preparations
05/21/2003EP0996468B1 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics
05/21/2003EP0981334B1 Swallow tablet comprising paracetamol
05/21/2003EP0966268B1 Cross-linked plant protein particles, in particular microparticles or nanoparticles, preparation method and cosmetic, pharmaceutical or food compositions containing same
05/21/2003EP0954290B1 Controlled-release pharmaceutical tablet containing a carrier based on cross-linked amylose and hydroxypropylmethylcellulose
05/21/2003EP0842658B1 Photostable aqueous solution containing benzyl alcohol derivatives
05/21/2003EP0837699B1 Immunovectors for the intracellular and intranuclear transport
05/21/2003EP0831703A4 Method of solubilizing and encapsulating itraconazole
05/21/2003EP0820285B1 Methods and compositions for lipidization of hydrophilic molecules
05/21/2003EP0706394B1 Use of a compostion comprising histamine phosphate for the manufacture of a medicament for the topical treatment of epithelial inflammation or lesions
05/21/2003EP0575545B1 Pegylation of polypeptides
05/21/2003CN1419565A Chimeric Prostate-homing peptides with pro-apoptotic activity
05/21/2003CN1419472A Lipid nanocapsules, preparation method and use and medicine
05/21/2003CN1419453A Pharmaceutical gel composition
05/21/2003CN1419451A Novel galneical form for oral administration with prolonged release of molsidomine
05/21/2003CN1419445A Agent and binding agent for pharmaceutical formulations with improved storage stability
05/21/2003CN1419444A Pharmaceutical composition of topiramate
05/21/2003CN1419441A Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent
05/21/2003CN1419438A Cosmetic and pharmaceutical compositions and methods usin 2-decarboxy-2-phophinico derivatives
05/21/2003CN1419437A Compositions and method for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
05/21/2003CN1419418A Method of producing oily suspensions of water-soluble vitamins
05/21/2003CN1418641A Polyester with its main train having amino acid and contg. active drug, and its prepn. method
05/21/2003CN1418618A Oral cavity disintegration type solid preparation and method for making same
05/21/2003CN1109103C Artificial culture of jiuzhou caterpillar fungus and the application of its sporophore
05/21/2003CN1109049C Adjuvent composition containing cyclodextrin and vaccine having same
05/21/2003CN1109047C Amphiapathic moleculs as cholesterol and other lipid uptake inhibitors
05/21/2003CN1109046C Induction of cytotoxic T-lymphocyte responses
05/21/2003CN1109041C Process for preparing substituted disulfide derivative and targeted form thereof
05/21/2003CN1108967C Metering valve
05/21/2003CN1108823C Excipient stabilization of polypeptides treated with organic solvents
05/21/2003CN1108822C Pharmaceutical composition containing lornoxicam and disodic salt of EDTA
05/21/2003CN1108814C Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates
05/21/2003CN1108790C Pharmaceutical compostion for transdermic delivery
05/21/2003CN1108788C Cosmetic compositions
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566506 Useful in extending the in vivo circulating life of biologically active materials
05/20/2003US6566409 Lock and key micelles
05/20/2003US6566406 Biocompatible crosslinked polymers
05/20/2003US6566350 Minocycline-containing compositions
05/20/2003US6566345 Polyacid/polyalkylene oxide foams and gels and methods for their delivery
05/20/2003US6566140 Inhibition of coagulation in blood and blood products
05/20/2003US6566084 Detecting hydrolysis of cocaine compound; obtain cocaine mixture, incubate with antibody, monitor generation of benzoic zacid
05/20/2003US6566082 T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditions
05/20/2003US6565885 Methods of spray drying pharmaceutical compositions
05/20/2003US6565883 Delay dissolving in water, gastric juice
05/20/2003US6565880 Antiinflammatory agents
05/20/2003US6565879 Neutralization; adjustment drug flux
05/20/2003US6565875 Microcapsules for administration of neuroactive agents
05/20/2003US6565874 Polymeric delivery formulations of leuprolide with improved efficacy
05/20/2003US6565866 Iodophor compositions
05/20/2003US6565859 Galenical formulations
05/20/2003US6565852 Tumor antigen; vaccine; antitumor, anticarcinogenic agents
1 ... 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 ... 1712